WAPL
Basic information
Region (hg38): 10:86435256-86521792
Previous symbols: [ "KIAA0261", "WAPAL" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WAPL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 49 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 50 | 0 | 0 |
Variants in WAPL
This is a list of pathogenic ClinVar variants found in the WAPL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-86437967-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
10-86443324-A-G | not specified | Uncertain significance (Nov 23, 2021) | ||
10-86446384-A-T | not specified | Uncertain significance (Sep 14, 2022) | ||
10-86446431-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
10-86452001-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
10-86452020-C-T | not specified | Uncertain significance (Jan 09, 2023) | ||
10-86452037-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
10-86452038-T-C | not specified | Uncertain significance (Nov 18, 2023) | ||
10-86452058-G-C | not specified | Uncertain significance (Jan 22, 2024) | ||
10-86452068-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
10-86452070-T-C | not specified | Uncertain significance (Oct 02, 2023) | ||
10-86452079-C-A | not specified | Uncertain significance (May 30, 2024) | ||
10-86453718-T-G | not specified | Uncertain significance (May 14, 2024) | ||
10-86453725-C-A | not specified | Uncertain significance (Dec 17, 2023) | ||
10-86453790-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
10-86460450-T-A | not specified | Uncertain significance (Dec 19, 2022) | ||
10-86467457-C-T | WAPL-related disorder | Uncertain significance (Mar 08, 2018) | ||
10-86467470-G-GTATA | not specified | Uncertain significance (Sep 14, 2022) | ||
10-86472218-G-A | 6 conditions | Uncertain significance (Dec 15, 2020) | ||
10-86472674-T-A | not specified | Uncertain significance (Dec 08, 2023) | ||
10-86472674-T-C | not specified | Uncertain significance (May 17, 2023) | ||
10-86472692-C-T | not specified | Uncertain significance (May 15, 2024) | ||
10-86472737-G-T | not specified | Uncertain significance (Feb 06, 2024) | ||
10-86497263-T-C | not specified | Uncertain significance (Jun 18, 2021) | ||
10-86497299-C-G | not specified | Uncertain significance (Apr 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WAPL | protein_coding | protein_coding | ENST00000298767 | 18 | 86560 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.27e-8 | 125720 | 0 | 2 | 125722 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.46 | 383 | 627 | 0.611 | 0.0000313 | 7915 |
Missense in Polyphen | 80 | 260.94 | 0.30658 | 3276 | ||
Synonymous | 1.04 | 199 | 218 | 0.911 | 0.0000108 | 2186 |
Loss of Function | 6.72 | 2 | 56.5 | 0.0354 | 0.00000327 | 697 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of sister chromatid cohesion in mitosis which negatively regulates cohesin association with chromatin. Involved in both sister chromatid cohesion during interphase and sister- chromatid resolution during early stages of mitosis. Couples DNA replication to sister chromatid cohesion. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15150110, ECO:0000269|PubMed:17112726, ECO:0000269|PubMed:17113138, ECO:0000269|PubMed:19696148, ECO:0000269|PubMed:19907496, ECO:0000269|PubMed:21111234, ECO:0000269|PubMed:23776203}.;
- Pathway
- Establishment of Sister Chromatid Cohesion;S Phase;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- rvis_EVS
- -1.2
- rvis_percentile_EVS
- 5.83
Haploinsufficiency Scores
- pHI
- 0.829
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.674
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Wapl
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- mitotic cell cycle;negative regulation of DNA replication;response to toxic substance;viral process;negative regulation of chromatin binding;meiotic chromosome segregation;negative regulation of sister chromatid cohesion;positive regulation of fibroblast proliferation;cell division;regulation of chromosome condensation;protein localization to chromatin;regulation of cohesin loading
- Cellular component
- chromosome, centromeric region;chromatin;synaptonemal complex;nucleus;nucleoplasm;chromosome;cytoplasm;cytosol;cohesin complex
- Molecular function
- protein binding